| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5927464 | American Heart Journal | 2015 | 22 Pages |
Abstract
The relative efficacy and safety of rivaroxaban vs warfarin was similar in patients with and without DM, supporting use of rivaroxaban as an alternative to warfarin in diabetic patients with AF.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Sameer MD, Zachary MD, Jonathan L. MD, Anne S. MS, Yuliya PhD, Manesh R. MD, Richard C. MD, Günter MD, Werner MD, Graeme J. MD, Christopher C. MD, Daniel E. MD, Scott D. MD, Jonathan P. MD, Kenneth W. MD, Keith A.A. MB, ChB,